Heonchang Lim is the Director of Formulation Development at Samsung Biologics' CDO division, where he leads a team dedicated to developing innovative drug formulations. With over 15 years of experience in the biopharmaceutical industry, Heonchang specializes in protein drugs and vaccines. He has successfully managed more than 50 formulation development and non-GMP DP manufacturing projects. In September 2022, he helped launch DEVELOPICK™, a platform that evaluates target molecules.Prior to joining Samsung Biologics in 2017, Heonchang served as a scientist at LG Chem, where he conducted R&D for purification and formulation development in multiple vaccine and protein drug projects. He holds a master's degree in medicine from Seoul National University and a bachelor's degree in molecular biology from Catholic University.